Sale of land by 3 PSU pharma firms cleared


The Cabinet on Wednesday approved the sale of surplus land of ailing state-owned pharma companies Indian Drugs & Pharmaceuticals Limited (IDPL), Rajasthan Drugs & Pharmaceuticals Limited (RDPL), and Bengal Chemicals & Pharmaceuticals Limited (BCPL) to pay off their existing liabilities.

While IDPL and RDPL will be closed down after settling their current liabilities, the Union government will explore the option to undertake a strategic sale of BCPL and Hindustan Antibiotics Limited at a later stage, according to an official statement.

In this way, the national assets would be utilized in the best national interest. The sale (of land) would be through open competitive bidding to government agencies and the outstanding liabilities will be met from the sale proceeds.”

The public sector firms have also been asked to implement a Voluntary Retirement Scheme and Voluntary Separation Scheme for their employees.

The remaining part of their land assets will be managed in accordance with norms set by the Department of Investment & Public Assets Management.

Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

PHYTOCON 2018 - Commercialization of medicinal plant products: Lab techniques to trade_14 April 2018